Hao Wang's Colleagues at QED Therapeutics
Hao Wang's Contact Details
HQ
650-231-4088
650-231-4088
Location
San Jose,California,United States
San Jose,California,United States
Company
QED Therapeutics
QED Therapeutics
Hao Wang's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Hao Wang
Hao Wang currently works for QED Therapeutics.
Hao Wang's role at QED Therapeutics is Associate Director.
Hao Wang's email address is ***@qedtx.com. To view Hao Wang's full email address, please signup to ConnectPlex.
Hao Wang works in the Research industry.
Hao Wang's colleagues at QED Therapeutics are Francesca Avogadri-Connors, Hiywot Takkele, Sherry Markle, Sudesh Kamath, Mag Sellakumaran, Kathleen Dm, Jack Winnike and others.
Hao Wang's phone number is 650-231-4088